41268 Federal Register / Vol. 63, No. 148 / Monday, August 3, 1998 / Notices

received during the open comment

period, the information obtained from

the three science symposia, and any

other relevant information. The NIEHS

Report to Congress will be prepared

following the October 9 deadline for

comments and is expected to be

submitted to Congress late 1998.

Written and/or oral comments on the

working group report are welcome as

described below:

Written Comments

The NIEHS invites interested public

to submit written comments providing

their perspective on the implications of

the Working Group Report to be

considered by the NIEHS as it prepares

a Report to Congress on the potential for

human health effects from exposure to

EMF resulting from the production and

distribution of electricity. Written

comments should be sent to the address

given below. All comments must be

received by October 9, 1998 and must

identify the person making the

comments and the sponsoring

organization (if any).

Oral Comments

To encourage and facilitate the

broadest base of input possible, the

NIEHS is hosting three meetings to

receive comments providing

perspectives on the implications of the

Working Group Report to be considered

by the NIEHS as it prepares a Report to

Congress on the potential for human

health effects from exposure to EMF

resulting from the production and

distribution of electricity. Oral

comments will be presented to NIEHS

officials with responsibility for

preparing the Report to Congress as well

as to other officials associated with the

implementation of the EMF Research

and Public Information Dissemination

(RAPID) Program, established by the

1992 Energy Policy Act (Section 2118

for Public Law 102–486). Meeting

locations follow; the hours for each

meeting will be 2–3:00 p.m. for

registration/welcome and the public

comment period will be held from 3–

8:00 p.m. unless all speakers have been

heard prior to that time (local time).

Date City Building Address

September 28 ............................... Washington, DC ............................ Ronald Reagan Trade Center ...... 1300 Pennsylvania Ave. NW.

October 1 ...................................... San Francisco, CA ........................ US EPA, Region IX ....................... 75 Hawthorne St.

October 5 ...................................... Chicago, IL .................................... University of Chicago, Gleacher

Center.

450 N Cityfront Plaza Drive.

Each speaker will be asked when

registering to identify their sponsoring

organization (if any). The number of

speakers representing the same

sponsoring organization may be limited

to one in order to assure time for as

many speakers and organizations to be

represented as possible. Brief

introductory comments will be

presented by the agencies represented

and the remainder of the time will be

devoted to the receipt of public

comments both oral and written. While

the time allotted for each presentation

will largely be dependent upon the

number of individuals who wish to

speak, it is anticipated that

approximately 5–6 minutes would be

available for each presenter to address

the panel. Speakers will be registered

and assigned time on a first-come, firstserve basis. To register to speak, provide

the following information: name,

affiliation, mailing address, phone, fax,

e-mail, sponsoring organization (if any)

to the address (mail, e-mail, fax) given

below. Registration is accepted on site

prior to the start of the meeting so that

the time available to each speaker can

be determined.

When oral comments are read from

printed copy, it is requested that copies

be provided when registering at the

meeting to supplement the record of the

meeting. Written statements may

expand on the oral presentation as well,

or may be submitted in lieu of an oral

presentation. It is important, however,

that all written statements, if not

provided at the time of the meeting, be

received by the October 9 deadline.

The meetings will be recorded to

establish a record of the comments for

use by the NIEHS in preparing the

Report to Congress. NIEHS staff will be

available to welcome and meet the

interested public during the registration

hour that will precede each meeting.

1998 Annual EMF Research Review—

Tucson, Arizona

An additional public comment period

on the Report will be held on the

afternoons of September 14–15, 1998, in

conjunction with the DOE/NIEHS/EEI

Annual EMF Research Review Meeting.

The meeting will be held at the

InnSuites, 475 N. Granada Ave., Tucson,

AZ 85701. Given that a number of

research scientists will be in attendance,

NIEHS and other officials with

responsibility for preparing the Report

to Congress will be available to receive

comments from meeting attendees or

from interested public. Anyone not

attending the conference but interested

in attending the afternoon open

comment sessions are asked to contact

the NIEHS EMF–RAPID Program as

described below:

REQUESTS FOR THE REPORT,

QUESTIONS, COMMENTS, OR TO

REGISTER FOR A PUBLIC MEETING,

please contact: by Mail: EMF–RAPID

Program/LCBRA NIEHS, NIH, P.O. Box

12233, MD EC–16, Research Triangle

Park, NC 27709, by fax: 919–541–0144,

or by e-mail: emf-rapid@niehs.nih.gov.

Dated: July 27, 1998.

Kenneth Olden,

Director, National Institute of Environmental

Health Sciences.

[FR Doc. 98–20545 Filed 7–31–98; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Substance Abuse and Mental Health

Services Administration

Current List of Laboratories Which

Meet Minimum Standards To Engage in

Urine Drug Testing for Federal

Agencies, and Laboratories That Have

Withdrawn From the Program

AGENCY: Substance Abuse and Mental

Health Services Administration, HHS.

ACTION: Notice.

SUMMARY: The Department of Health and

Human Services notifies Federal

agencies of the laboratories currently

certified to meet standards of Subpart C

of Mandatory Guidelines for Federal

Workplace Drug Testing Programs (59

FR 29916, 29925). A similar notice

listing all currently certified laboratories

will be published during the first week

of each month, and updated to include

laboratories which subsequently apply

for and complete the certification

process. If any listed laboratory’s

certification is totally suspended or

revoked, the laboratory will be omitted

from updated lists until such time as it

is restored to full certification under the

Guidelines.
Federal Register / Vol. 63, No. 148 / Monday, August 3, 1998 / Notices 41269

If any laboratory has withdrawn from

the National Laboratory Certification

Program during the past month, it will

be identified as such at the end of the

current list of certified laboratories, and

will be omitted from the monthly listing

thereafter.

This Notice is now available on the

internet at the following website: http:/

/www.health.org.

FOR FURTHER INFORMATION CONTACT: Mrs.

Giselle Hersh or Dr. Walter Vogl,

Division of Workplace Programs, 5600

Fishers Lane, Rockwall 2 Building,

Room 815, Rockville, Maryland 20857;

Tel.: (301) 443–6014.

Special Note: Our office moved to a

different building on May 18, 1998. Please

use the above address for all regular mail and

correspondence. For all overnight mail

service use the following address: Division of

Workplace Programs, 5515 Security Lane,

Room 815, Rockville, Maryland 20852.

SUPPLEMENTARY INFORMATION:

Mandatory Guidelines for Federal

Workplace Drug Testing were developed

in accordance with Executive Order

12564 and section 503 of Pub. L. 100–

71. Subpart C of the Guidelines,

‘‘Certification of Laboratories Engaged

in Urine Drug Testing for Federal

Agencies,’’ sets strict standards which

laboratories must meet in order to

conduct urine drug testing for Federal

agencies. To become certified an

applicant laboratory must undergo three

rounds of performance testing plus an

on-site inspection. To maintain that

certification a laboratory must

participate in a quarterly performance

testing program plus periodic, on-site

inspections.

Laboratories which claim to be in the

applicant stage of certification are not to

be considered as meeting the minimum

requirements expressed in the HHS

Guidelines. A laboratory must have its

letter of certification from SAMHSA,

HHS (formerly: HHS/NIDA) which

attests that it has met minimum

standards.

In accordance with Subpart C of the

Guidelines, the following laboratories

meet the minimum standards set forth

in the Guidelines:

ACL Laboratories, 8901 W. Lincoln Ave.

West Allis, WI 53227, 414–328–7840

(formerly: Bayshore Clinical

Laboratory)

Aegis Analytical Laboratories, Inc., 345

Hill Ave., Nashville, TN 37210, 615–

255–2400

Alabama Reference Laboratories, Inc.,

543 South Hull St., Montgomery, AL

36103, 800–541–4931/334–263–5745

Alliance Laboratory Services, 3200

Burnet Ave. Cincinnati, OH 45229,

513–569–2051 (formerly: Jewish

Hospital of Cincinnati, Inc.)

American Medical Laboratories, Inc.,

14225 Newbrook Dr., Chantilly, VA

20151, 703–802–6900

Associated Pathologists Laboratories,

Inc., 4230 South Burnham Ave., Suite

250, Las Vegas, NV 89119–5412, 702–

733–7866 / 800–433–2750

Associated Regional and University

Pathologists, Inc. (ARUP), 500 Chipeta

Way, Salt Lake City, UT 84108, 801–

583–2787 / 800–242–2787

Baptist Medical Center—Toxicology

Laboratory, 9601 I–630, Exit 7, Little

Rock, AR 72205–7299, 501–202–2783

(formerly: Forensic Toxicology

Laboratory Baptist Medical Center)

Cedars Medical Center, Department of

Pathology, 1400 Northwest 12th Ave.,

Miami, FL 33136, 305–325–5784

Clinical Reference Lab, 8433 Quivira

Rd., Lenexa, KS 66215–2802, 800–

445–6917

Cox Health Systems, Department of

Toxicology, 1423 North Jefferson

Ave., Springfield, MO 65802, 800–

876–3652/417–269–3093 (formerly:

Cox Medical Centers)

Dept. of the Navy, Navy Drug Screening

Laboratory, Great Lakes, IL, P.O. Box

88–6819, Great Lakes, IL 60088–6819,

847–688–2045/847–688–4171

Diagnostic Services Inc., dba DSI, 12700

Westlinks Drive, Fort Myers, FL

33913, 941–561–8200/800–735–5416

Doctors Laboratory, Inc., P.O. Box 2658,

2906 Julia Dr., Valdosta, GA 31604,

912–244–4468

DrugProof, Division of Dynacare/

Laboratory of Pathology, LLC, 1229

Madison St., Suite 500, Nordstrom

Medical Tower, Seattle, WA 98104,

800–898–0180/206–386–2672

(formerly: Laboratory of Pathology of

Seattle, Inc., DrugProof, Division of

Laboratory of Pathology of Seattle,

Inc.)

DrugScan, Inc., P.O. Box 2969, 1119

Mearns Rd., Warminster, PA 18974,

215–674–9310

Dynacare Kasper Medical Laboratories*,

14940–123 Ave., Edmonton, Alberta,

Canada T5V 1B4, 800–661–9876/403–

451–3702

ElSohly Laboratories, Inc., 5 Industrial

Park Dr., Oxford, MS 38655, 601–236–

2609

Gamma-Dynacare Medical

Laboratories*, a Division of the

Gamma-Dynacare Laboratory

Partnership, 245 Pall Mall St.,

London, ON, Canada N6A 1P4, 519–

679–1630

General Medical Laboratories, 36 South

Brooks St., Madison, WI 53715, 608–

267–6267

Hartford Hospital Toxicology

Laboratory, 80 Seymour St., Hartford,

CT 06102–5037, 860–545–6023

Info-Meth, 221 N.E. Glen Oak Ave.,

Peoria, IL 61636, 800–752–1835/309–

671–5199 (formerly: Methodist

Medical Center Toxicology

Laboratory)

LabCorp Occupational Testing Services,

Inc., 1904 Alexander Drive, Research

Triangle Park, NC 27709, 919–672–

6900/800–833–3984 (formerly:

CompuChem Laboratories, Inc.;

CompuChem Laboratories, Inc., a

subsidiary of Roche Biomedical

Laboratory; Roche CompuChem

Laboratories, Inc., a Member of the

Roche Group)

LabCorp Occupational Testing Services,

Inc., 4022 Willow Lake Blvd.,

Memphis, TN 38118, 901–795–1515/

800–223–6339 (formerly:

MedExpress/National Laboratory

Center)

LabOne, Inc., 8915 Lenexa Dr., Overland

Park, Kansas 66214, 913–888–3927/

800–728–4064 (formerly: Center for

Laboratory Services, a Division of

LabOne, Inc.)

Laboratory Corporation of America, 888

Willow St., Reno, NV 89502, 702–

334–3400 (formerly: Sierra Nevada

Laboratories, Inc.)

Laboratory Corporation of America

Holdings, 69 First Ave., Raritan, NJ

08869, 800–437–4986/908–526–2400,

(formerly: Roche Biomedical

Laboratories, Inc.)

Laboratory Specialists, Inc., 1111

Newton St., Gretna, LA 70053, 504–

361–8989/800–433–3823

Marshfield Laboratories, Forensic

Toxicology Laboratory, 1000 North

Oak Ave., Marshfield, WI 54449, 715–

389–3734/800–331–3734

MAXXAM Analytics Inc.*, 5540

McAdam Rd., Mississauga, ON,

Canada L4Z 1P1, 905–890–2555

(formerly: NOVAMANN (Ontario)

Inc.)

Medical College Hospitals Toxicology

Laboratory, Department of Pathology,

3000 Arlington Ave., Toledo, OH

43614, 419–381–5213

Medlab Clinical Testing, Inc., 212

Cherry Lane, New Castle, DE 19720,

302–655–5227

MedTox Laboratories, Inc., 402 W.

County Rd. D, St. Paul, MN 55112,

800–832–3244/612–636–7466

Methodist Hospital Toxicology Services

of Clarian Health Partners, Inc.,

Department of Pathology and

Laboratory Medicine, 1701 N. Senate

Blvd., Indianapolis, IN 46202, 317–

929–3587

MetroLab-Legacy Laboratory Services,

1225 NE 2nd Ave., Portland, OR

97232, 503–413–4512, 800–950–5295

Minneapolis Veterans Affairs Medical

Center, Forensic Toxicology

Laboratory, 1 Veterans Drive,

Minneapolis, Minnesota 55417, 612–

725–2088
41270 Federal Register / Vol. 63, No. 148 / Monday, August 3, 1998 / Notices

National Toxicology Laboratories, Inc.,

1100 California Ave., Bakersfield, CA

93304, 805–322–4250

Northwest Toxicology, Inc., 1141 E.

3900 South, Salt Lake City, UT 84124,

800–322–3361/801–268–2431

Oregon Medical Laboratories, P.O. Box

972, 722 East 11th Ave., Eugene, OR

97440–0972, 541–341–8092

Pacific Toxicology Laboratories, 1519

Pontius Ave., Los Angeles, CA 90025,

310–312–0056 (formerly: Centinela

Hospital Airport Toxicology

Laboratory

Pathology Associates Medical

Laboratories, 11604 E. Indiana,

Spokane, WA 99206, 509–926–2400/

800–541–7891

PharmChem Laboratories, Inc., 1505–A

O’Brien Dr., Menlo Park, CA 94025,

650–328–6200/800–446–5177

PharmChem Laboratories, Inc., Texas

Division 7610 Pebble Dr., Fort Worth,

TX 76118, 817–595–0294 (formerly:

Harris Medical Laboratory)

Physicians Reference Laboratory, 7800

West 110th St., Overland Park, KS

66210, 913–339–0372/800–821–3627

Poisonlab, Inc., 7272 Clairemont Mesa

Blvd., San Diego, CA 92111, 619–279–

2600/800–882–7272

Premier Analytical Laboratories, 15201

East I–10 Freeway, Suite 125,

Channelview, TX 77530, 713–457–

3784/800–888–4063 (formerly: Drug

Labs of Texas)

Presbyterian Laboratory Services, 5040

Airport Center Parkway, Charlotte, NC

28208, 800–473–6640 / 704–943–3437

Quest Diagnostics Incorporated, 4444

Giddings Road, Auburn Hills, MI

48326, 810–373–9120 / 800–444–0106

(formerly: HealthCare/Preferred

Laboratories, HealthCare/MetPath,

CORNING Clinical Laboratories)

Quest Diagnostics Incorporated,

National Center for Forensic Science,

1901 Sulphur Spring Rd., Baltimore,

MD 21227, 410–536–1485 (formerly:

Maryland Medical Laboratory, Inc.,

National Center for Forensic Science,

CORNING National Center for

Forensic Science)

Quest Diagnostics Incorporated, 4770

Regent Blvd., Irving, TX 75063, 800–

526–0947 / 972–916–3376 (formerly:

Damon Clinical Laboratories, Damon/

MetPath, CORNING Clinical

Laboratories)

Quest Diagnostics Incorporated, 875

Greentree Rd., 4 Parkway Ctr.,

Pittsburgh, PA 15220–3610, 800–574–

2474 / 412–920–7733 (formerly: MedChek Laboratories, Inc., Med-Chek/

Damon, MetPath Laboratories,

CORNING Clinical Laboratories)

Quest Diagnostics Incorporated, 2320

Schuetz Rd., St. Louis, MO 63146,

800–288–7293 / 314–991–1311

(formerly: Metropolitan Reference

Laboratories, Inc., CORNING Clinical

Laboratories, South Central Division)

Quest Diagnostics Incorporated, 7470

Mission Valley Rd., San Diego, CA

92108–4406, 800–446–4728 / 619–

686–3200 (formerly: Nichols Institute,

Nichols Institute Substance Abuse

Testing (NISAT), CORNING Nichols

Institute, CORNING Clinical

Laboratories)

Quest Diagnostics Incorporated, One

Malcolm Ave., Teterboro, NJ 07608,

201–393–5590 (formerly: MetPath,

Inc., CORNING MetPath Clinical

Laboratories, CORNING Clinical

Laboratory)

Quest Diagnostics Incorporated, 1355

Mittel Blvd., Wood Dale, IL 60191,

630–595–3888 (formerly: MetPath,

Inc., CORNING MetPath Clinical

Laboratories, CORNING Clinical

Laboratories Inc.)

Scientific Testing Laboratories, Inc., 463

Southlake Blvd., Richmond, VA

23236, 804–378–9130

Scott & White Drug Testing Laboratory,

600 S. 31st St., Temple, TX 76504,

800–749–3788 / 254–771–8379

S.E.D. Medical Laboratories, 500 Walter

NE, Suite 500, Albuquerque, NM

87102, 505–727–8800 / 800–999-

LABS

SmithKline Beecham Clinical

Laboratories, 3175 Presidential Dr.,

Atlanta, GA 30340, 770–452–1590

(formerly: SmithKline Bio-Science

Laboratories)

SmithKline Beecham Clinical

Laboratories, 8000 Sovereign Row,

Dallas, TX 75247, 214–637–7236

(formerly: SmithKline Bio-Science

Laboratories)

SmithKline Beecham Clinical

Laboratories, 801 East Dixie Ave.,

Leesburg, FL 34748, 352–787–9006

(formerly: Doctors & Physicians

Laboratory)

SmithKline Beecham Clinical

Laboratories, 400 Egypt Rd.,

Norristown, PA 19403, 800–877–7484

/ 610–631–4600 (formerly:

SmithKline Bio-Science Laboratories)

SmithKline Beecham Clinical

Laboratories, 506 E. State Pkwy.,

Schaumburg, IL 60173, 847–447–

4379/800–447–4379 (formerly:

International Toxicology Laboratories)

SmithKline Beecham Clinical

Laboratories, 7600 Tyrone Ave., Van

Nuys, CA 91405, 818–989–2520 /

800–877–2520

South Bend Medical Foundation, Inc.,

530 N. Lafayette Blvd., South Bend,

IN 46601, 219–234–4176

Southwest Laboratories, 2727 W.

Baseline Rd., Tempe, AZ 85283, 602–

438–8507

Sparrow Health System, Toxicology

Testing Center, St. Lawrence Campus,

1210 W. Saginaw, Lansing, MI 48915,

517–377–0520 (formerly: St.

Lawrence Hospital & Healthcare

System)

St. Anthony Hospital Toxicology

Laboratory, 1000 N. Lee St.,

Oklahoma City, OK 73101, 405–272–

7052

Toxicology & Drug Monitoring

Laboratory, University of Missouri

Hospital & Clinics, 2703 Clark Lane,

Suite B, Lower Level, Columbia, MO

65202, 573–882–1273

Toxicology Testing Service, Inc., 5426

N.W. 79th Ave., Miami, FL 33166,

305–593–2260

UNILAB, 18408 Oxnard St., Tarzana,

CA 91356, 800–492–0800 / 818–996–

7300 (formerly: MetWest-BPL

Toxicology Laboratory)

Universal Toxicology Laboratories, LLC,

10210 W. Highway 80, Midland,

Texas 79706, 915–561–8851 / 888–

953–8851

UTMB Pathology-Toxicology

Laboratory, University of Texas

Medical Branch, Clinical Chemistry

Division, 301 University Boulevard,

Room 5.158, Old John Sealy,

Galveston, Texas 77555–0551, 409–

772–3197

*The Standards Council of Canada (SCC)

voted to end its Laboratory Accreditation

Program for Substance Abuse (LAPSA)

effective May 12, 1998. Laboratories certified

through that program were accredited to

conduct forensic urine drug testing as

required by U.S. Department of

Transportation (DOT) regulations. As of that

date, the certification of those accredited

Canadian laboratories will continue under

DOT authority. The responsibility for

conducting quarterly performance testing

plus periodic on-site inspections of those

LAPSA-accredited laboratories was

transferred to the U.S. DHHS, with the

DHHS’ National Laboratory Certification

Program (NLCP) contractor continuing to

have an active role in the performance testing

and laboratory inspection processes. Other

Canadian laboratories wishing to be

considered for the NLCP may apply directly

to the NLCP contractor just as U.S.

laboratories do. Upon finding a Canadian

laboratory to be qualified, the DHHS will

recommend that DOT certify the laboratory

(Federal Register, 16 July 1996) as meeting

the minimum standards of the ‘‘Mandatory

Guidelines for Workplace Drug Testing’’ (59

Federal Register, 9 June 1994, Pages 29908–

29931). After receiving the DOT certification,

the laboratory will be included in the

monthly list of DHHS certified laboratories

and participate in the NLCP certification

maintenance program.

Richard Kopanda,

Executive Officer, Substance Abuse and

Mental Health Services Administration.

[FR Doc. 98–20573 Filed 7–31–98; 8:45 am]

BILLING CODE 4160–20–P